HUP0001913A2 - Pramipexole alkalmazása állandóan mozgó láb szindróma kezelésére szolgáló gyógyszerkészítmények előállítására - Google Patents

Pramipexole alkalmazása állandóan mozgó láb szindróma kezelésére szolgáló gyógyszerkészítmények előállítására

Info

Publication number
HUP0001913A2
HUP0001913A2 HU0001913A HUP0001913A HUP0001913A2 HU P0001913 A2 HUP0001913 A2 HU P0001913A2 HU 0001913 A HU0001913 A HU 0001913A HU P0001913 A HUP0001913 A HU P0001913A HU P0001913 A2 HUP0001913 A2 HU P0001913A2
Authority
HU
Hungary
Prior art keywords
preparation
pramipexole
restless legs
legs syndrome
pharmaceutical compositions
Prior art date
Application number
HU0001913A
Other languages
English (en)
Inventor
Baltazar Gomez-Mancilla
Dieter Meier
Jacques Montplaisir
Wolfgang H. Oertel
Original Assignee
Boehringer Ingelheim Pharma Kg
Pharmacia & Upjohn Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg, Pharmacia & Upjohn Co. filed Critical Boehringer Ingelheim Pharma Kg
Publication of HUP0001913A2 publication Critical patent/HUP0001913A2/hu
Publication of HUP0001913A3 publication Critical patent/HUP0001913A3/hu
Publication of HU226564B1 publication Critical patent/HU226564B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Corsets Or Brassieres (AREA)
  • Semiconductor Memories (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

A találmány tárgya 2-amino-6-n-propil-amino-4,5,6,7-tetrahidro-benztiazol (-)-enantiomerjének vagy gyógyászatilag elfogadható sójánakaz alkalmazása állandóanmozgóláb-szindróma betegségtől szenvedő vagyilyen állapotra érzékeny beteg kezelésére alkalmas gyógyszerelőállítására. Ó
HU0001913A 1997-01-17 1998-01-16 Use of pramipexole for the preparation of pharmaceutical compositions treating restless legs syndrome HU226564B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19701619A DE19701619B4 (de) 1997-01-17 1997-01-17 Verwendung von Pramipexol zur Behandlung des restless legs syndroms
PCT/US1998/000216 WO1998031362A1 (en) 1997-01-17 1998-01-16 Use of pramipexole in the treatment of restless legs syndrome

Publications (3)

Publication Number Publication Date
HUP0001913A2 true HUP0001913A2 (hu) 2000-11-28
HUP0001913A3 HUP0001913A3 (en) 2002-09-30
HU226564B1 HU226564B1 (en) 2009-04-28

Family

ID=7817708

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0001913A HU226564B1 (en) 1997-01-17 1998-01-16 Use of pramipexole for the preparation of pharmaceutical compositions treating restless legs syndrome

Country Status (24)

Country Link
EP (1) EP0989850B1 (hu)
JP (2) JP4406685B2 (hu)
KR (2) KR100761774B1 (hu)
CN (1) CN1117564C (hu)
AT (1) ATE281165T1 (hu)
AU (1) AU723119B2 (hu)
BG (1) BG64614B1 (hu)
CA (1) CA2275379C (hu)
CZ (1) CZ289863B6 (hu)
DE (2) DE19701619B4 (hu)
ES (1) ES2231959T3 (hu)
FI (1) FI120135B (hu)
HK (1) HK1024408A1 (hu)
HU (1) HU226564B1 (hu)
NO (1) NO321151B1 (hu)
NZ (2) NZ336804A (hu)
PL (1) PL190898B1 (hu)
PT (1) PT989850E (hu)
RO (1) RO120757B1 (hu)
RU (1) RU2192252C2 (hu)
SI (1) SI20060A (hu)
SK (1) SK284264B6 (hu)
WO (1) WO1998031362A1 (hu)
ZA (1) ZA98420B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001861A (en) * 1998-01-16 1999-12-14 Pharmacia & Upjohn Company Use of pramipexole in the treatment of restless legs syndrome
DE19701619B4 (de) * 1997-01-17 2007-10-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Pramipexol zur Behandlung des restless legs syndroms
SE9803760D0 (sv) * 1998-11-04 1998-11-04 Jan Hedner Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel
DE19938825A1 (de) * 1999-08-19 2001-04-26 Boehringer Ingelheim Pharma Wirkstoffkombination mit Clonidin
DE10220230A1 (de) * 2002-05-06 2003-11-27 Sanol Arznei Schwarz Gmbh Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
EP1940398A1 (de) * 2005-10-18 2008-07-09 Boehringer Ingelheim International GmbH Verwendung von pramipexol zur behandlung des moderaten bis schweren restless legs syndroms (rls)
JP5769923B2 (ja) * 2006-04-03 2015-08-26 テバ ファーマシューティカル インダストリーズ リミティド レストレスレッグス症候群の治療のためのラサギリンの使用
TR200906997A1 (tr) 2009-09-11 2011-03-21 Sanovel �La� San. Ve T�C. A. �. Pramipeksol farmasötik bileşimleri.
TR200907554A1 (tr) 2009-10-06 2011-04-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Oral yolla dağılan pramıpexole bileşimleri.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE45735T1 (de) * 1984-12-22 1989-09-15 Thomae Gmbh Dr K Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arnzneimittel.
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
DE3933738A1 (de) * 1989-10-10 1991-04-11 Boehringer Ingelheim Kg Neue verwendung von 2-aminothiazol-derivaten (tsh)
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
DE4125446A1 (de) * 1991-08-01 1993-02-04 Uwe Dipl Ing Behmann Verfahren und einrichtung zur elektrischen kurzschlusspruefung und -ortung fuer leitungen, insbesondere fuer fahrleitungen elektrischer bahnen
US5598352A (en) * 1994-09-30 1997-01-28 Cirrus Logic, Inc. Method and apparatus for audio and video synchronizing in MPEG playback systems
US5650420A (en) * 1994-12-15 1997-07-22 Pharmacia & Upjohn Company Pramipexole as a neuroprotective agent
DE19701619B4 (de) * 1997-01-17 2007-10-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Pramipexol zur Behandlung des restless legs syndroms

Also Published As

Publication number Publication date
DE19701619B4 (de) 2007-10-11
BG64614B1 (bg) 2005-09-30
WO1998031362A1 (en) 1998-07-23
CN1117564C (zh) 2003-08-13
CN1243439A (zh) 2000-02-02
ATE281165T1 (de) 2004-11-15
NZ336804A (en) 2001-03-30
KR100761774B1 (ko) 2007-10-04
SI20060A (sl) 2000-04-30
BG103543A (en) 2000-04-28
JP2009062388A (ja) 2009-03-26
AU723119B2 (en) 2000-08-17
RO120757B1 (ro) 2006-07-28
CZ289863B6 (cs) 2002-04-17
SK284264B6 (sk) 2004-12-01
NO993360L (no) 1999-07-07
AU6016898A (en) 1998-08-07
KR20000070234A (ko) 2000-11-25
SK92099A3 (en) 2000-08-14
FI120135B (fi) 2009-07-15
PL190898B1 (pl) 2006-02-28
JP4406685B2 (ja) 2010-02-03
KR20050085947A (ko) 2005-08-29
NO321151B1 (no) 2006-03-27
NZ510007A (en) 2004-11-26
JP2001511158A (ja) 2001-08-07
EP0989850A1 (en) 2000-04-05
FI991616A (fi) 1999-07-16
PL334498A1 (en) 2000-02-28
DE19701619A1 (de) 1998-07-23
RU2192252C2 (ru) 2002-11-10
HUP0001913A3 (en) 2002-09-30
ES2231959T3 (es) 2005-05-16
CZ247899A3 (cs) 2000-01-12
HU226564B1 (en) 2009-04-28
ZA98420B (en) 1999-07-19
EP0989850B1 (en) 2004-11-03
CA2275379C (en) 2006-11-28
DE69827387D1 (de) 2004-12-09
NO993360D0 (no) 1999-07-07
DE69827387T2 (de) 2005-10-27
CA2275379A1 (en) 1998-07-23
HK1024408A1 (en) 2000-10-13
PT989850E (pt) 2004-12-31

Similar Documents

Publication Publication Date Title
DE69400799T2 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
HUP0303363A2 (hu) Kináz-inhibitor hatású heterociklusos vegyületek alkalmazása gyógyszerkészítmények előállítására
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
NO20092874L (no) Forhindring og behandling av amyloidogen sykdom
MXPA04004966A (es) Nucleosidos de 3-beta-d-ribofuranoziltiazol(4,5-d(pirimidina y uso de los mismos.
HK1069316A1 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
ATE142877T1 (de) Melatoninderivate zur behandlung von schlafstörungen und zur pre-anästhesie
BG101118A (en) Therapeutical compounds
MXPA04005886A (es) Derivados de azaindolilalquilamina como ligandos de 5-hidroxitirptamina-6.
DE60312736D1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
DE50010284D1 (de) Arzneimittel zur behandlung von bluthochdruck
BR0210392A (pt) Composto, métodos de tratar um paciente que tenha ou de prevenir um paciente de contrair uma doença ou condição e de preparar um composto, e, uso de um composto
HUP0203716A2 (hu) Tumorellenes hatású szubsztituált (N-benzil-indol-3-il)-glioxilsav-származékok, ezeket tartalmazó gyógyszerkészítmények
HUP0402304A2 (hu) Deutériummal helyettesített dihidrofuranonszármazékok és azokat tartalmazó gyógyszerkészítmények
HUP0001913A2 (hu) Pramipexole alkalmazása állandóan mozgó láb szindróma kezelésére szolgáló gyógyszerkészítmények előállítására
DE60220055D1 (de) 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden
HUP0100080A2 (hu) Mirtazapin alkalmazása alvásiapnoe kezelésére szolgáló gyógyszerkészítmény előállítására
NO20000771D0 (no) Anvendelse av fankinon for behandling av Alzheimers sykdom
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
BR0212249A (pt) Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto
DE59109130D1 (de) Arzneimittel enthaltend einen quisqualat-rezeptor-antagonisten und einen dopamin-agonisten zur behandlung des morbus parkinson
BR9812531A (pt) Combinação de componentes, preparação farmacêutica, produção desta, e, uso da combinação ou da preparação farmacêutica
DE69621786T2 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
RU99118211A (ru) Применение прамипексола в лечении синдрома усталых ног

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: PHARMACIA & UPJOHN COMPANY LLC, US

Free format text: FORMER OWNER(S): PHARMACIA & UPJOHN CO., US

Owner name: BOEHRINGER INGELHEIM PHARMA KG, DE

Free format text: FORMER OWNER(S): PHARMACIA & UPJOHN CO., US

GB9A Succession in title

Owner name: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG, DE

Free format text: FORMER OWNER(S): BOEHRINGER INGELHEIM PHARMA KG, DE; PHARMACIA & UPJOHN CO., US; PHARMACIA & UPJOHN COMPANY LLC, US